Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for China Pharma Holdings, Inc. (CPHI : AMEX)
 
 • Company Description   
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.

Number of Employees: 231

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.84 Daily Weekly Monthly
20 Day Moving Average: 150,566 shares
Shares Outstanding: 3.26 (millions)
Market Capitalization: $6.00 (millions)
Beta: 0.79
52 Week High: $3.35
52 Week Low: $1.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 14.07% 9.00%
12 Week 30.31% 11.30%
Year To Date -20.86% -25.87%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Second Floor No. 17 Jinpan Road
-
Haikou,F4 570216
CHN		 ph: 86-898-6681-1730
fax: 86-898-6681-9024		 hps@chinapharmaholdings.com http://www.chinapharmaholdings.com
 
 • General Corporate Information   
Officers
Zhilin Li - Chief Executive Officer;Chairperson; President and
Heung Mei Tsui - Director
Gene Michael Bennett - Director
Yingwen Zhang - Director
Baowen Dong - Director

Peer Information
China Pharma Holdings, Inc. (BGMR)
China Pharma Holdings, Inc. (BBIO)
China Pharma Holdings, Inc. (IPAH)
China Pharma Holdings, Inc. (BRL)
China Pharma Holdings, Inc. (BHC)
China Pharma Holdings, Inc. (AKRXQ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 16941T401
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 3.26
Most Recent Split Date: 4.00 (0.10:1)
Beta: 0.79
Market Capitalization: $6.00 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.86
Price/Cash Flow: -
Price / Sales: 1.40
EPS Growth
vs. Year Ago Period: 65.71%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -17.08%
vs. Previous Quarter: 0.18%
ROE
06/30/25 - -
03/31/25 - -63.74
12/31/24 - -63.19
ROA
06/30/25 - -
03/31/25 - -32.14
12/31/24 - -32.22
Current Ratio
06/30/25 - -
03/31/25 - 0.56
12/31/24 - 0.65
Quick Ratio
06/30/25 - -
03/31/25 - 0.17
12/31/24 - 0.20
Operating Margin
06/30/25 - -
03/31/25 - -106.31
12/31/24 - -104.57
Net Margin
06/30/25 - -
03/31/25 - -106.31
12/31/24 - -104.57
Pre-Tax Margin
06/30/25 - -
03/31/25 - -106.31
12/31/24 - -104.57
Book Value
06/30/25 - -
03/31/25 - 2.14
12/31/24 - 2.38
Inventory Turnover
06/30/25 - -
03/31/25 - 2.56
12/31/24 - 2.31
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.20
12/31/24 - 0.18
Debt-to-Capital
06/30/25 - -
03/31/25 - 16.66
12/31/24 - 15.22
 

Powered by Zacks Investment Research ©